Development of medications for the treatment of opiate and cocaine addictions: issues for the government and private sector
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
National Academy Press
1995
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse Includes bibliographical references Introduction -- Overview of the state of scientific knowledge concerning drug addiction -- Assessment of the medications development division -- Treatment setting and effectiveness -- Treatment financing and trends in health insurance -- Training and education -- Federal laws and regulations -- State laws and regulations -- Market obstacles and creating incentives |
| Beschreibung: | 1 Online-Ressource (xvii, 250 pages) |
| ISBN: | 0309052440 058502541X 9780309052443 9780585025414 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043084283 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s1995 |||| o||u| ||||||eng d | ||
| 020 | |a 0309052440 |9 0-309-05244-0 | ||
| 020 | |a 0309052440 |9 0-309-05244-0 | ||
| 020 | |a 058502541X |c electronic bk. |9 0-585-02541-X | ||
| 020 | |a 9780309052443 |9 978-0-309-05244-3 | ||
| 020 | |a 9780585025414 |c electronic bk. |9 978-0-585-02541-4 | ||
| 035 | |a (OCoLC)42329146 | ||
| 035 | |a (DE-599)BVBBV043084283 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.86/32061 |2 20 | |
| 245 | 1 | 0 | |a Development of medications for the treatment of opiate and cocaine addictions |b issues for the government and private sector |c Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| 264 | 1 | |a Washington, DC |b National Academy Press |c 1995 | |
| 300 | |a 1 Online-Ressource (xvii, 250 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Introduction -- Overview of the state of scientific knowledge concerning drug addiction -- Assessment of the medications development division -- Treatment setting and effectiveness -- Treatment financing and trends in health insurance -- Training and education -- Federal laws and regulations -- State laws and regulations -- Market obstacles and creating incentives | ||
| 650 | 4 | |a Substance-Related Disorders / drug therapy | |
| 650 | 4 | |a Narcotics | |
| 650 | 4 | |a Cocaine | |
| 650 | 4 | |a Legislation, Drug / United States | |
| 650 | 4 | |a Drug Industry / United States | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Neurology |2 bisacsh | |
| 650 | 7 | |a Cocaine abuse / Treatment |2 fast | |
| 650 | 7 | |a Drug addiction / Treatment |2 fast | |
| 650 | 7 | |a Substance abuse / Treatment |2 fast | |
| 650 | 7 | |a Cocain |2 swd | |
| 650 | 7 | |a Drogenabhängigkeit |2 swd | |
| 650 | 7 | |a Drogentherapie |2 swd | |
| 650 | 7 | |a Opiate |2 swd | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Drug addiction |x Treatment | |
| 650 | 4 | |a Cocaine abuse |x Treatment | |
| 650 | 4 | |a Substance abuse |x Treatment | |
| 650 | 0 | 7 | |a Cocain |0 (DE-588)4128249-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Opiate |0 (DE-588)4075669-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Drogentherapie |0 (DE-588)4122122-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 689 | 0 | 0 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |D s |
| 689 | 0 | 1 | |a Cocain |0 (DE-588)4128249-8 |D s |
| 689 | 0 | 2 | |a Drogentherapie |0 (DE-588)4122122-9 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |D s |
| 689 | 1 | 1 | |a Opiate |0 (DE-588)4075669-5 |D s |
| 689 | 1 | 2 | |a Drogentherapie |0 (DE-588)4122122-9 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Fulco, Carolyn |e Sonstige |4 oth | |
| 700 | 1 | |a Liverman, Catharyn T. |e Sonstige |4 oth | |
| 700 | 1 | |a Earley, Laurence E. |e Sonstige |4 oth | |
| 710 | 2 | |a National Institute on Drug Abuse |b Committee to Study Medication Development and Research |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Division of Biobehavioral Sciences and Mental Disorders |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028508475 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175479062659072 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043084283 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)42329146 (DE-599)BVBBV043084283 |
| dewey-full | 616.86/32061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.86/32061 |
| dewey-search | 616.86/32061 |
| dewey-sort | 3616.86 532061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04268nmm a2200841zc 4500</leader><controlfield tag="001">BV043084283</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s1995 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309052440</subfield><subfield code="9">0-309-05244-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309052440</subfield><subfield code="9">0-309-05244-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">058502541X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-585-02541-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309052443</subfield><subfield code="9">978-0-309-05244-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780585025414</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-585-02541-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)42329146</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043084283</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.86/32061</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of medications for the treatment of opiate and cocaine addictions</subfield><subfield code="b">issues for the government and private sector</subfield><subfield code="c">Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">National Academy Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvii, 250 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- Overview of the state of scientific knowledge concerning drug addiction -- Assessment of the medications development division -- Treatment setting and effectiveness -- Treatment financing and trends in health insurance -- Training and education -- Federal laws and regulations -- State laws and regulations -- Market obstacles and creating incentives</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Narcotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cocaine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Nervous System (incl. Brain)</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Neurology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cocaine abuse / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug addiction / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance abuse / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cocain</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogentherapie</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Opiate</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug addiction</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cocaine abuse</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance abuse</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cocain</subfield><subfield code="0">(DE-588)4128249-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Cocain</subfield><subfield code="0">(DE-588)4128249-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fulco, Carolyn</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liverman, Catharyn T.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Earley, Laurence E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Institute on Drug Abuse</subfield><subfield code="b">Committee to Study Medication Development and Research</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Division of Biobehavioral Sciences and Mental Disorders</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028508475</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043084283 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:16:56Z |
| institution | BVB |
| isbn | 0309052440 058502541X 9780309052443 9780585025414 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028508475 |
| oclc_num | 42329146 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xvii, 250 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | National Academy Press |
| record_format | marc |
| spelling | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine Washington, DC National Academy Press 1995 1 Online-Ressource (xvii, 250 pages) txt rdacontent c rdamedia cr rdacarrier Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse Includes bibliographical references Introduction -- Overview of the state of scientific knowledge concerning drug addiction -- Assessment of the medications development division -- Treatment setting and effectiveness -- Treatment financing and trends in health insurance -- Training and education -- Federal laws and regulations -- State laws and regulations -- Market obstacles and creating incentives Substance-Related Disorders / drug therapy Narcotics Cocaine Legislation, Drug / United States Drug Industry / United States HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) bisacsh MEDICAL / Neurology bisacsh Cocaine abuse / Treatment fast Drug addiction / Treatment fast Substance abuse / Treatment fast Cocain swd Drogenabhängigkeit swd Drogentherapie swd Opiate swd Medizin Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment Cocain (DE-588)4128249-8 gnd rswk-swf Drogenabhängigkeit (DE-588)4138597-4 gnd rswk-swf Opiate (DE-588)4075669-5 gnd rswk-swf Drogentherapie (DE-588)4122122-9 gnd rswk-swf USA Drogenabhängigkeit (DE-588)4138597-4 s Cocain (DE-588)4128249-8 s Drogentherapie (DE-588)4122122-9 s 1\p DE-604 Opiate (DE-588)4075669-5 s 2\p DE-604 Fulco, Carolyn Sonstige oth Liverman, Catharyn T. Sonstige oth Earley, Laurence E. Sonstige oth National Institute on Drug Abuse Committee to Study Medication Development and Research Sonstige oth Institute of Medicine (U.S.) Division of Biobehavioral Sciences and Mental Disorders Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Substance-Related Disorders / drug therapy Narcotics Cocaine Legislation, Drug / United States Drug Industry / United States HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) bisacsh MEDICAL / Neurology bisacsh Cocaine abuse / Treatment fast Drug addiction / Treatment fast Substance abuse / Treatment fast Cocain swd Drogenabhängigkeit swd Drogentherapie swd Opiate swd Medizin Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment Cocain (DE-588)4128249-8 gnd Drogenabhängigkeit (DE-588)4138597-4 gnd Opiate (DE-588)4075669-5 gnd Drogentherapie (DE-588)4122122-9 gnd |
| subject_GND | (DE-588)4128249-8 (DE-588)4138597-4 (DE-588)4075669-5 (DE-588)4122122-9 |
| title | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_auth | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_exact_search | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_full | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| title_fullStr | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| title_full_unstemmed | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| title_short | Development of medications for the treatment of opiate and cocaine addictions |
| title_sort | development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_sub | issues for the government and private sector |
| topic | Substance-Related Disorders / drug therapy Narcotics Cocaine Legislation, Drug / United States Drug Industry / United States HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) bisacsh MEDICAL / Neurology bisacsh Cocaine abuse / Treatment fast Drug addiction / Treatment fast Substance abuse / Treatment fast Cocain swd Drogenabhängigkeit swd Drogentherapie swd Opiate swd Medizin Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment Cocain (DE-588)4128249-8 gnd Drogenabhängigkeit (DE-588)4138597-4 gnd Opiate (DE-588)4075669-5 gnd Drogentherapie (DE-588)4122122-9 gnd |
| topic_facet | Substance-Related Disorders / drug therapy Narcotics Cocaine Legislation, Drug / United States Drug Industry / United States HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) MEDICAL / Neurology Cocaine abuse / Treatment Drug addiction / Treatment Substance abuse / Treatment Cocain Drogenabhängigkeit Drogentherapie Opiate Medizin Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1130 |
| work_keys_str_mv | AT fulcocarolyn developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector AT livermancatharynt developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector AT earleylaurencee developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector AT nationalinstituteondrugabusecommitteetostudymedicationdevelopmentandresearch developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector AT instituteofmedicineusdivisionofbiobehavioralsciencesandmentaldisorders developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector |